| AU757510C              (en) | 1998-08-27 | 2003-09-11 | Medimmune Limited | Pyrrolobenzodiazepines | 
| GB9818730D0              (en) | 1998-08-27 | 1998-10-21 | Univ Portsmouth | Collections of compounds | 
| GB9818732D0              (en) | 1998-08-27 | 1998-10-21 | Univ Portsmouth | Collection of compounds | 
| GB9818731D0              (en) | 1998-08-27 | 1998-10-21 | Univ Portsmouth | Compounds | 
| US6909006B1              (en) | 1999-08-27 | 2005-06-21 | Spirogen Limited | Cyclopropylindole derivatives | 
| FR2835186B1              (en) | 2002-01-28 | 2006-10-20 | Aventis Pharma Sa | NOVEL HETEROCYCLIC COMPOUNDS ACTIVE AS BETA-LACTAMASES INHIBITORS | 
| FR2844273B1              (en) | 2002-09-05 | 2008-04-04 | Aventis Pharma Sa | NOVEL HETEROCYCLIC COMPOUNDS, METHOD AND INTERMEDIARY PREPARATION AND USE AS MEDICAMENT, IN PARTICULAR AS INHIBITORS OF BETA-LACTAMASES AND ANTI-BACTERIALS. | 
| GB0226593D0              (en) | 2002-11-14 | 2002-12-24 | Consultants Ltd | Compounds | 
| US7439253B2              (en) | 2002-12-06 | 2008-10-21 | Novexel | Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors | 
| FR2848210B1              (en)* | 2002-12-06 | 2007-10-19 | Aventis Pharma Sa | NOVEL HETEROCYCLIC COMPOUNDS, PREPARATION THEREOF AND THEIR USE AS MEDICAMENTS, IN PARTICULAR AS ANTI-BACTERIALS AND INHIBITORS OF BETA-LACTAMASES | 
| GB0321295D0              (en) | 2003-09-11 | 2003-10-15 | Spirogen Ltd | Synthesis of protected pyrrolobenzodiazepines | 
| GB0404577D0              (en) | 2004-03-01 | 2004-04-07 | Spirogen Ltd | Pyrrolobenzodiazepines | 
| ES2398975T3              (en) | 2004-03-01 | 2013-03-25 | Spirogen Sàrl | 11-Hydroxy-5H-pyrrolo [2,1-c] [1,4] benzodiazepin-5-one derivatives as key intermediates for the preparation of C2 substituted pyrrolobenzodiazepines | 
| EP1723152B1              (en) | 2004-03-09 | 2015-02-11 | Spirogen Sàrl | Pyrrolobenzodiazepines | 
| GB0819095D0              (en) | 2008-10-17 | 2008-11-26 | Spirogen Ltd | Pyrrolobenzodiazepines | 
| AU2011239522B2              (en) | 2010-04-15 | 2014-10-23 | Medimmune Limited | Targeted pyrrolobenzodiazapine conjugates | 
| NZ602933A              (en) | 2010-04-15 | 2014-09-26 | Seattle Genetics Inc | Pyrrolobenzodiazepines used to treat proliferative diseases | 
| GB201006340D0              (en) | 2010-04-15 | 2010-06-02 | Spirogen Ltd | Synthesis method and intermediates | 
| CN103987718A              (en) | 2011-09-20 | 2014-08-13 | 斯皮罗根有限公司 | Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugates | 
| ES2945932T3              (en) | 2011-10-14 | 2023-07-10 | Seagen Inc | Pyrrolobenzodiazepines and targeted conjugates | 
| JP6166728B2              (en) | 2011-10-14 | 2017-07-19 | メドイミューン・リミテッドMedImmune Limited | Synthetic methods and intermediates useful for the preparation of pyrrolobenzodiazepines | 
| AU2012322613B2              (en) | 2011-10-14 | 2016-04-21 | Medimmune Limited | Pyrrolobenzodiazepines and targeted conjugates | 
| EA028457B1              (en) | 2011-10-14 | 2017-11-30 | Медимьюн Лимитед | Pyrrolobenzodiazepines | 
| BR112014008981A2              (en) | 2011-10-14 | 2017-05-02 | Spirogen Sàrl | pyrrolobenzodiazepines | 
| WO2014057114A1              (en) | 2012-10-12 | 2014-04-17 | Adc Therapeutics Sàrl | Pyrrolobenzodiazepine-anti-psma antibody conjugates | 
| KR20150083994A              (en) | 2012-10-12 | 2015-07-21 | 스피로즌 살 | Pyrrolobenzodiazepines and conjugates thereof | 
| PT2766048E              (en) | 2012-10-12 | 2015-02-25 | Spirogen Sarl | PYRROLOBENZODIAZEPINES AND CONJUGATES OF THE SAME | 
| TR201808051T4              (en) | 2012-10-12 | 2018-06-21 | Adc Therapeutics Sa | Pyrrolobenzodiazepine antibody conjugates. | 
| ES2660029T3              (en) | 2012-10-12 | 2018-03-20 | Medimmune Limited | Antibody-pyrrolobenzodiazepine conjugates | 
| DK2906251T3              (en) | 2012-10-12 | 2017-11-20 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-anti-CD22-antibody conjugates | 
| AU2013328673B2              (en) | 2012-10-12 | 2017-07-13 | Medimmune Limited | Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation | 
| DK2906253T3              (en) | 2012-10-12 | 2018-10-22 | Adc Therapeutics Sa | Pyrrolobenzodiazepine anti-PSMA antibody conjugates | 
| SMT201900017T1              (en) | 2012-10-12 | 2019-02-28 | Medimmune Ltd | Pyrrolobenzodiazepine-antibody conjugates | 
| GB201317981D0              (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof | 
| GB201317982D0              (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof | 
| WO2015052534A1              (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates | 
| WO2015052535A1              (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates | 
| US10010624B2              (en) | 2013-10-11 | 2018-07-03 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates | 
| GB201416112D0              (en) | 2014-09-12 | 2014-10-29 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof | 
| BR112017011111A2              (en) | 2014-11-25 | 2017-12-26 | Adc Therapeutics Sa | pyrrolobenzodiazepine-antibody conjugates | 
| GB201506402D0              (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates | 
| GB201506411D0              (en) | 2015-04-15 | 2015-05-27 | Bergenbio As | Humanized anti-axl antibodies | 
| GB201601431D0              (en) | 2016-01-26 | 2016-03-09 | Medimmune Ltd | Pyrrolobenzodiazepines | 
| GB201602359D0              (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates | 
| GB201602356D0              (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates | 
| GB201607478D0              (en) | 2016-04-29 | 2016-06-15 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates | 
| GB201617466D0              (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates | 
| DK3544636T3              (en) | 2017-02-08 | 2021-05-10 | Adc Therapeutics Sa | Pyrrolobenzodiazepine antibody conjugates | 
| GB201702031D0              (en) | 2017-02-08 | 2017-03-22 | Medlmmune Ltd | Pyrrolobenzodiazepine-antibody conjugates | 
| SI3612537T1              (en) | 2017-04-18 | 2022-10-28 | Medimmune Limited | Pyrrolobenzodiazepine conjugates | 
| US20200129637A1              (en) | 2017-04-20 | 2020-04-30 | Adc Therapeutics Sa | Combination therapy with an anti-axl antibody-drug conjugate | 
| WO2018229222A1              (en) | 2017-06-14 | 2018-12-20 | Adc Therapeutics Sa | Dosage regimes for the administration of an anti-cd19 adc | 
| KR102270107B1              (en) | 2017-08-18 | 2021-06-30 | 메디뮨 리미티드 | pyrrolobenzodiazepine conjugate | 
| GB201803342D0              (en) | 2018-03-01 | 2018-04-18 | Medimmune Ltd | Methods | 
| GB201806022D0              (en) | 2018-04-12 | 2018-05-30 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof | 
| ES2967878T3              (en) | 2019-03-15 | 2024-05-06 | Medimmune Ltd | Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer |